Vaccine safety came into sharp focus last week when AstraZeneca Plc paused late-stage clinical trials of its COVID-19 vaccine
16 Sep 2020 10:05 AM
Adverse effects were noted on two human subjects who volunteered for the phase 3 trials of AstraZeneca COVID-19 vaccine
11 Sep 2020 1:15 PM